Pharma Focus Asia

FUJIFILM Diosynth Biotechnologies Starts North Carolina Facility Expansion

Introduction:

FUJIFILM Diosynth Biotechnologies has started the expansion of its North Carolina facility expansion project.

Features:

The 31,778 square foot addition will increase cell culture manufacturing by approximately 25 per cent and microbial capacity by approximately 50 per cent with the installation of new recovery and purification suites. A new receiving warehouse is also included in the project.

This project will enable to further increase its capacity to efficiently meet current and future customer demands in a modern facility.

The company expects that the increased production capacity for cGMP manufacture will be ready by mid-2021.

Specifications:

NameFUJIFILM Diosynth Biotechnologies
TypeExpansion
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference